PharmaRoth Labs (CE) Stock Price

0.0002 (40.0%)
Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
PharmaRoth Labs Inc (CE) ROTH OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0002 40.0% 0.0007 15:56:57
Open Price Low Price High Price Close Price Prev Close
0.0008 0.0006 0.0008 0.0007 0.0005
Bid Price Ask Price Spread News
0.0005 0.0005 0.00 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6 489,472 $ 0.000767 $ 375 - 0.000001 - 0.0052
Last Trade Time Type Quantity Stock Price Currency
15:56:57 206,250 $ 0.0007 USD

PharmaRoth Labs (CE) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 245.83k 351.18M 200.12M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
26.50k $ - 0.00% - -

more financials information »

PharmaRoth Labs (CE) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ROTH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00080.00080.00040.0007694128,625-0.0001-12.5%
1 Month0.00070.0010.0000010.0006244217,1770.000.0%
3 Months0.0010.0010.0000010.0004808199,678-0.0003-30.0%
6 Months0.00140.00160.0000010.0006256231,780-0.0007-50.0%
1 Year0.00060.00520.0000010.00241741,459,2050.000116.67%
3 Years0.003450.00520.0000010.0022139973,016-0.00275-79.71%
5 Years0.00650.0140.0000010.0026572709,823-0.0058-89.23%

PharmaRoth Labs (CE) Description

PharmaRoth Labs, Inc. is focused on diabetes prevention and treatments. The Company holds the intellectual property and all exclusive world-wide rights related to the production, marketing, and distribution of Sucanon(R), an oral treatment for Type-II diabetes. Sucanon(R) is a member of a class of diabetic medications called insulin sensitizers. Insulin sensitizers lower blood sugar by increasing the muscle, fat and liver's sensitivity to insulin. Insulin sensitizers are blood sugar normalizing or euglycemic drugs that help return the blood sugar to the normal range without the risk of low blood sugars. PharmaRoth's strategy is to increase awareness, acceptance, and distribution of Sucanon(R) globally.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.